TCT-650: In Vivo Tissue Characterization of Coronary Lipid Plaques: Comparison of Optical Coherence Tomography and Near-Infrared Spectroscopy  by unknown
TUESDAY, NOVEMBER 8, 2011, 8:00 AM - 10:00 AM
(MACE).
Results: Between June 2009 and March 2011, 18 consecutive patients with an under-
expanded stent despite high pressure balloon inflation were included. The mean age
was 70.4±10.4 years, 11 patients (61.2%) were male, and diabetes mellitus was present
in 9 patients (50.0%) Target lesions included 1 (5.6%) in the distal left mainstem, 11
(61.1) in the left anterior descending artery, 3 (16.7%) in the left circumflex and 3
(16.7%) right coronary artery. The mean catheter size was 1.2±0.4 (range 0.9-2.0mm)
and a mean of 3610±1824 laser pulses were required for optimal expansion. Optimal
stent dilatation was achieved in 17 cases (94.4%), with an improvement in minimum
lumen diameter measured by QCA (1.59mm at baseline to 2.78mm post-procedure)
and minimum stent area measured by IVUS (3.80mm2 to 7.99mm2). Periprocedural
MI was observed in 2 patients and transient slow flow in 1 patient following ELCA.
During follow-up, MACE occurred in 1 patient (5.5%) who underwent TLR.
Conclusion: The ELLEMENT study confirms the efficacy and reproducibility of
ELCA with contrast injection in improving stent underexpansion in undilatable lesions.
TCT-647
Two Year Follow Up Data of Orbital Atherectomy System for the Treatment of
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Background: Coronary Artery Disease continues to be a widespread and growing
problem worldwide. Performing PCI on calcified lesions can lead to higher MACE
rates and stent under expansion/malapposition. The Orbit I trial was conducted to
evaluate the safety and performance of the Diamondback 360 Orbital Atherectomy
System (OAS) (Cardiovascular Systems, Inc., St. Paul, MN, USA) for the treatment
of calcified coronary lesions.
Methods: From May 2008 to July 2008, a single-center subset of 33 non-consecutive
patients from the ORBIT I study were enrolled at CIMS Hospital Pvt. Ltd., India center
based on several criteria, including a de novo, coronary lesion with stenosis ≥50% and
≤100% and at least one quadrant of calcification via IVUS. The patients were treated
with OAS prior to stent placement. The safety endpoint was MACE rates, and patients
were followed to two years at this center.
Results: Of the 33 patients, 90.90% (n=30/33) were male and the average age was
54.9 years. The ACC/AHA lesion class was: Type A 6.06% (n=2/33); Type B1 33.33%
(n=11/33); Type B2 60.60% (n=20/33). The % diameter stenosis was 85.75%; lesion
length was 15.90 mm. The procedural success was 97% (32/33) with one case where
IVUS/device was not able to cross the lesion due to severe calcification. The observed
MACE rate was as follows: in-hospital 6.06% (n=2/33); 30 days 9.09% (n=3/33); 6
months 12.12% (n=4/33) and 2 years 15.15% (n=5/33). MACE rate comprised of 2
patients with a non Q-wave MI in-hospital; one patient with non Q-wave MI at 30 days
that led to TLR; and one patient with cardiac death at 6 months and at 2 years
respectively. All stents were successfully deployed with 0.3% ± 1.8% residual stenosis.
Conclusion: This case series demonstrates that OAS safely and effectively modified
calcified lesions and facilitated stent delivery in this difficult-to-treat plaque
morphology, which continues up to two years post-procedure.
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Background: The amount of neointimal hyperplasia (IH) following drug-eluting stent
(DES) implantation correlates with the potency of the anti-proliferative drug, its kinetic
release as well as some individual characteristics, as the presence of diabetes mellitus
(DM). Recently, some publications have suggested a continuous growth of IH
following DES, which in some cases, might result in late “catch-up”. The aim of this
study was to assess, by means of serial intravascular ultrasound (IVUS) the temporal
course of IH formation following the implantation of two different generation of DES
(durable-polymer sirolimus-eluting stent[SES] and biodegradable-polymer biolimus-
eluting stent[BES])
Methods: Twenty-five pts with single de novo lesions in native coronary arteries, with
reference vessel diameter between 2.5 and 3.5 mm were treated with Cypher-SES
(n=12) and Biomatrix-BES (n=13), and underwent IVUS evaluation post procedure,
at a mean of 9 months and 5 years.
Results: The mean age was 59 years, with 28% of DM. Baseline characteristics did
not differ between the groups. Overall, percentage of IH obstruction and IH volume
markedly increased from mid to long-term FU(percentage IH obstruction of 1.3% at
1st FU vs. 4.8% 2nd FU, p=0.002; mean IH volume 1.8 mm3 at 1st FU vs. 6.3 mm3
2nd FU, p=0.005). There was no significant difference in the variation (Δ) of vessel
volume, lumen volume and percentage of IH obstruction between DES. In a separate
analysis, sorting out patients according to diabetic status (7 diabetics and 18 non-
diabetics), a more pronounced IH increase among diabetics was noticed (mean IH
volume at 2nd FU 10.15 mm3 DM vs. 5.11 mm3 non-DM, p=0.02; percentage of IH
obstruction at 2nd FU 8.3% DM vs. 3.5% non-DM, p=0.02).
Conclusion: The present serial IVUS assessment represents the longest serial invasive
assessment of two generations DES with durable and biodegradable polymers. The
findings of this study support the occurrence of continuous IH growth following the
implantation of DES, these observations seem to be particularly
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Background: Atherosclerotic plaques with thin fibrous caps, large lipid pools, and
high densities of macrophages are more prone to rupture and cause acute coronary
syndromes. Optical frequency domain imaging (OFDI) can identify key components
related to plaque vulnerability but may suffer from artifacts and ambiguities that could
prevent accurate identification of lipid rich regions.
Methods: We present a model of depth resolved spectral analysis for intracoronary
plaque classification. Comprehensive pullback image datasets were acquired within
20 coronary arteries from 8 explant human hearts. Time-frequency analysis was used
to generate depth resolved spectra of OFDI interferometric signals. A training set of
registered OFDI-histology pairs (n=150) was used to develop a prediction model using
quadratic discriminant analysis. Inputs to the model included attenuation,
backscattering, and wavelength dependent attenuation. Model output is the probability
for each pixel being assigned to lipid, calcium, fibrous, adventitial fat, or noise. The
resultant spectroscopic diagnosis was compared to histological diagnosis.
Results: Using correlated OFDI and histology images, depth resolved spectral analysis
was able to classify lipid, calcium, fibrous regions, adventitial fat, and noise with
significant (p<0.001) areas under the receiver operator characteristic curve (0.87, 0.83,
0.97, 0.89, and 0.99 respectively). Although the backscattering and attenuation
coefficients were significantly different between tissue types (p<0.001), the addition
of spectral parameters increase the classification accuracy of lipid (AUC=0.87 with
spectral parameters, AUC=0.84 without) and adventitial fat (AUC=0.89 with spectral
parameters, AUC=0.87 without), p<0.05.
Conclusion: We have developed a method for classification of intracoronary OFDI
pullbacks. This method can increase the contrast of OFDI intracoronary images and
facilitate a rapid comprehensive visualization of OFDI datasets, which can potentially
improve OFDI diagnosis and/or assist in guiding therapeutic procedures.
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Background: Intravascular imaging with Fourier domain optical coherence
tomography produces high-resolution images (10–20 μm) of coronary atherosclerosis.
The LipiScan IVUS Coronary Imaging System combines co-registered grayscale
intravascular ultrasound (IVUS) with near infrared spectroscopy (NIRS) to identify
lipid-rich plaques. The concordance between these 2 imaging modalities has not been
studied.
Methods: 10 vessels were interrogated with both the Dragonfly OCT (pullback speed
=20mm/sec) and the IVUS/Lipiscan catheter (pullback speed 0.5mm/sec). A fiduciary
branch was identified for each pullback. Offline frame by frame analysis of the images
was performed to identify lipid pools. By OCT, lipid-rich plaque was defined as a
signal-poor region with diffuse borders.By NIRS, lipid-rich plaque was defined as a
high lipid core burden index, which has been validated against histology.
Results: There was excellent correlation between the spatial lipid pool distribution as
noted on OCT and NIRS, with an average 5 mm discrepancy between the two
modalities (possibly due to variations in guide catheter and wire position and imaging
catheter positioning). An example appears in the Figure. Small lipid pools which did
not extend beyond 1-2 frames were noted on only one or the other imaging system,
which might be explained by the varying distance of the light source from the small
lipid pool, differences in penetration, or false positives/negatives.
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Conclusion: There was very good correlation between the presence, absence, and
spatial distribution of lipid pools as noted on OCT and NIRS imaging. Larger studies
are required to determine whether NIRS and OCT provide complementary information
for plaque characterization.
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Background: Reduction in the hyper-echogenicity characteristics of the ABSORB
scaffold has been demonstrated to be related to the recovery of vasoreactivity of the
scaffolded segment at 2 years. Subsequent changes in the platform design and
manufacturing processes lead to significant prolongation in the lumen support with a
new revision of the device . We sought to correlate the reduction in hyper-echogenicity
of the revised ABSORB with the recovery of vaso-reactivity of the scaffolded segment
during this time period.
Methods: All patients from the ABSORB trial, who underwent paired echogenicity
analyses and vasomotion testing at 6 (ABSORB Cohort B1) or 12 (ABSORB Cohort
B2) months follow-up, were included in the analysis. Vasoreactivity was calculated as
relative mean lumen diameter (MLD) changes from pre to post acetylcholine
administration
Results: Overall, 31 patients underwent paired IVUS derived echogenicity analyses
and vasomotion testing at 6 (n=14) and 12-month (n=17) follow-up respectively. The
reduction in hyper-echogenicity of the scaffolded segment in the acetylcholine test
group went from 20.04±10.01 % to 18.09±10.01%, (p=0.561) and from 23.89 ± 9.99
% to 18.16 ± 8.70 % (p=0.006) at 6 and 12 months, respectively. The changes in MLD
after administration of acethylcoline were 1% of vasodilation (p=0.405 ) and 4%
vasoconstriction (p=0.086) at 6 and 12 months, respectively. A significant relationship
between the changes in hyper-echogenicity and in MLD after acethylcoline
administration was demonstrated at 12 months (Spearman rho=-0.678, p=0.0154), but
not at 6 months (Spearman rho=-0.3778, p=0.252)
Conclusion: The reduction in hyperechogenecity of the scaffolded segment is
significantly correlated with the restoration of the vasomotor activities of a coronary
segment scaffolded by the ABSORB scaffold at a long-term follow-up. This is
consistent with the programmed loss of structural integrity of the scaffold at that time
point.
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Background: Anatomo-pathological data indicate that coronary plaques prone to
rupture and erosion tend to cluster within the proximal third of each coronary vessel.
Intracoronary NIRS is a novel method to detect lipid core plaques (LCP). We sought
to assess the spatial distribution of lipid core plaques (LCP) by means of near infra red
spectroscopy (NIRS) in coronary arteries.
Methods: Sixty-eight consecutive patients underwent NIRS imaging on a non culprit
coronary artery. The region of interest (ROI) was subsequently divided into 10-mm
segments from proximal to distal. The 2-mm long block chemogram value (probability
of LCP, ranging from 0–low probability- to 1 –high probability) was assessed per ROI
and per each 10-mm segment.
Results: Overall, the length of the ROI was 58.0±4.3 mm, subdivided into 10-mm
segments for a total of 392 analyzed segments. There was a progressive decrease of
LCP from proximal to distal in the various 10-mm segments (1st 0.41[0.34-0.48] vs.
2nd 0.35[0.29-0.42] vs. 3rd 0.37[0.30-0.43] vs. 4th 0.32[0.26-0.39] vs. 5th 0.26[0.20-
0.33] vs. 6th 0.26[0.19-0.33], p=0.011). While in LAD and in LCx, LCP tended to
cluster in the proximal segment (p<0.001 and p=0.001, respectively), in the RCA they
were evenly distributed along the artery (p=0.155). At logistic regression analysis,
distance from the ostium was the only independent predictor of LCP.
Conclusion: Lipid-core plaques, as detected by NIRS, cluster in the proximal segment
of the coronary arteries, in distribution similar to that observed in prior autopsy studies.
The distribution of LCP is similar to that of the culprit lesions of STEMI patients.
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Background: The long-term serial change of stent strut coverage and neointima
characteristics in DESs have not been fully investigated with OCT. This study tried to
evaluate the serial quantitative and qualitative changes of vascular response in drug
eluting stents (DES) at 9 months and 2 years using optical coherence tomography
(OCT).
Methods: The OCT was performed serially in 80 DESs of 76 patients at 9 months and
2 years after DESs implantation (sirolimus-eluting stent [SES], n=23; paclitaxel-eluting
stent [PES], n=20; zotarolimus-eluting stent [ZES], n=25, everolimus-eluting stent
[EES], n=12). Serial change of quantitative (neointimal thickness, stent strut coverage
and apposition at each strut) and qualitative characteristics were evaluated.
Results: The incidence of uncovered stent strut significantly decreases from 9 months
to 2 years follow-up (4.9 % to 2.6 %, p<0.001), but there was similar for malapposition
rate (1.0 % to 1.1 %, p=0.63) and incidence of intracoronary thrombi (10.0 % to 8.8
%, p=0.79). In qualitative evaluation, lipid laden neointima (13.8% to 26.3%, p=0.03)
and intimal disruption (13.8% to 33.8%, p=0.03) were more frequently detected at 2
years follow-up compared to 9 months follow-up.
Conclusion: This OCT study suggested that neointimal coverage improved from 9
months to 2 years, but prevalence of malappostion and thrombus was not changed
during extended follow-up. Additionally, the neoatherosclerosis including transforming
into lipid laden neointima might progress between 9 months and 2 year-follow period.
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Quantitative multi-modality imaging analysis of a fully bioresorbable scaffold:
a head-to-head comparison between QCA, IVUS and OCT
Juan Luis Gutiérrez-Chico1, Patrick W Serruys1, Chrysafios Girasis1, Yoshinobu
Onuma1, Salvatore Brugaletta1, Héctor Manuel García-García2, Evelyn Regar1
1Interventional Cardiology, Erasmus Medical Center - Thoraxcenter, Rotterdam,
Netherlands; 2Cardialysis BV, Rotterdam, Netherlands
Background: The bioresorbable vascular scaffold (BVS) has peculiar imaging
characteristics, like total translucency and radiolucency. We analyze the agreement
between QCA, IVUS and OCT in the BVS for length and minimum lumen area (MLA)
measurements immediately post-implantation and at 6 months.
Methods: Patients enrolled in the ABSORB cohort B1 study (NCT00856856)
underwent coronary angiography, IVUS and OCT immediately post BVS implantation
and at 6 months. Agreement between QCA edge detection (ED), QCA
videodensitometry (VD), IVUS and OCT regarding scaffold length and MLA was
analyzed through intraclass correlation coefficients and Passing-Bablock non-
parametric orthogonal regression.
Results: 45 patients were sequentially imaged. OCT estimates scaffold length
accurately compared to nominal length (95% CI of the difference: -0.15; 0.34 and -
0.13; 0.47mm for baseline and 6 months, respectively), whereas QCA incurs consistent
underestimation of the same magnitude at both time points (Pearson correlation =
0.806). IVUS yields low accuracy (95% CI of the difference: 1.04; 3.24 and -0.56;
2.65mm2 for baseline and 6 months, respectively), with several outliers and random
variability test-retest. MLA decreases substantially between baseline and 6 months in
QCA and OCT, but only minimally in IVUS (95% CI: 0.12, 0.52 mm2). ICCa and
Bland-Altman show poor agreement for MLA between the different imaging
modalities: worst agreement ED-IVUS post-implantation (ICCa 0.253); best agreement
IVUS-OCT at 6 months (ICCa 0.767). All the pairs deviated significantly from linearity
(p<0.01). Passing-Bablock non-parametric orthogonal regression showed constant and
proportional bias between IVUS and OCT.
Conclusion: OCT is the most accurate technique for measurement of scaffold length;
QCA incurs systematic underestimation (foreshortening) and IVUS is the most
inaccurate and unpredictable modality. This has implications for volumetric
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